Alcidion Group (ASX:ALC) EV-to-EBIT: 38.70 (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Alcidion Group EV-to-EBIT?

Alcidion Group ASX:ALC +1.03% EV-to-EBIT is 38.70 as of Jul. 18, 2026. The stock has 4 warning signs investors should review. Among 470 Healthcare Providers & Services companies, Alcidion Group ranks worse than 82.77% on this metric.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Alcidion Group's Enterprise Value is A$118.47 Mil. Alcidion Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$3.06 Mil. Therefore, Alcidion Group's EV-to-EBIT for today is 38.70.

The historical rank and industry rank for Alcidion Group's EV-to-EBIT or its related term are showing as below:

ASX:ALC' s EV-to-EBIT Range Over the Past 10 Years
Min: -1509.68   Med: -13.3   Max: 377.97
Current: 38.7

During the past 13 years, the highest EV-to-EBIT of Alcidion Group was 377.97. The lowest was -1509.68. And the median was -13.30.

ASX:ALC's EV-to-EBIT is ranked worse than
82.77% of 470 companies
in the Healthcare Providers & Services industry
Industry Median: 15.72 vs ASX:ALC: 38.70

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Alcidion Group's Enterprise Value for the quarter that ended in Dec. 2025 was A$127.81 Mil. Alcidion Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$3.06 Mil. Alcidion Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 2.39%.


Alcidion Group  (ASX:ALC) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Alcidion Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2025 ) =EBIT / Enterprise Value (Q: Dec. 2025 )
=3.061/127.813065
=2.39 %

Alcidion Group's Enterprise Value for the quarter that ended in Dec. 2025 was A$127.81 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Alcidion Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$3.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alcidion Group EV-to-EBIT Related Terms


Alcidion Group EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Alcidion Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alcidion Group EV-to-EBIT Chart

Alcidion Group Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -423.61 -32.46 -23.40 -6.32 294.27

Alcidion Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -6.32 0.00 294.27 0.00

ASX:ALC vs VEEV, BTSG, TEM: EV-to-EBIT Comparison

For the Health Information Services subindustry, Alcidion Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alcidion Group EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alcidion Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Alcidion Group's EV-to-EBIT falls into.



Alcidion Group EV-to-EBIT Calculation

Alcidion Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=118.472/3.061
=38.70

Alcidion Group's current Enterprise Value is A$118.47 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Alcidion Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$3.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of 38.70 mean?
Alcidion Group (ASX:ALC) has a EV-to-EBIT of 38.70 as of Jul. 18, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Alcidion Group and its competitors. According to the industry distribution chart, Alcidion Group ranks #389 out of 470 companies in the Healthcare Providers & Services industry, placing it in the top 82.8%.
Is Alcidion Group's EV-to-EBIT too high?
Alcidion Group's current EV-to-EBIT is 38.70. The Healthcare Providers & Services industry median EV-to-EBIT is 15.72. Alcidion Group's value of 38.70 is 146.2% above this industry median. Based on the distribution chart, Alcidion Group ranks #389 out of 470 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Alcidion Group's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Alcidion Group ranks #389 out of 470 companies for EV-to-EBIT. This places Alcidion Group in the lower half of its industry. The industry median EV-to-EBIT is 15.72. Alcidion Group's value of 38.70 is 146.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.72, based on 470 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alcidion Group's current EV-to-EBIT of 38.70 is 146.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Alcidion Group and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcidion Group's current EV-to-EBIT is 38.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcidion Group stock overvalued right now?
Based on GuruFocus' analysis, Alcidion Group (ASX:ALC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.12, compared to a current price of A$0.10 — trading 18.3% below its estimated fair value. The current EV-to-EBIT is 38.70 and 146.2% above the Healthcare Providers & Services industry median of 15.72. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Alcidion Group (ASX:ALC), the current EV-to-EBIT is 38.70 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alcidion Group Business Description

Address 9 Yarra Street, Level 10, South Yarra, Melbourne, VIC, AUS, 3141
Alcidion Group Ltd is a provider of intelligent informatics software. It offers a fully integrated digital patient care platform that includes a clinical decision support (CDS) system, Electronic Patient Record (EPR), and Patient Administration System (PAS). Alcidion is engaged in the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of healthcare software products from its strategic partners, and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in the United Kingdom, Australia, and New Zealand. The company generates maximum revenue from the United Kingdom.